Accelerate Diagnostics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Accelerate Diagnostics generated cash of -$40,196,000, which is more than the previous year. Cash used in financing activities reached the amount of $9,019,000 last year. Net change in cash is therefore -$22,767,000.
Cash Flow
| 2014 | -18.78M | -3.37M | 45.69M |
|---|---|---|---|
| 2015 | -35.12M | -2.67M | 104.82M |
| 2016 | -53.40M | -49.56M | 1.76M |
| 2017 | -55.74M | -25.72M | 90.42M |
| 2018 | -67.75M | -20.13M | 125.77M |
| 2019 | -64.79M | 52.81M | 6.82M |
| 2020 | -50.39M | 13.60M | 11.63M |
| 2021 | -47.32M | 8.30M | 43.22M |
| 2022 | -48.72M | 12.41M | 31.63M |
| 2023 | -40.19M | 8.66M | 9.01M |
0H8E.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 34.90M | 39.89M | 35.78M | 61.01M | 66.26M | 28.51M | 19.24M | 120.58M | 53.56M | 30.02M |
Operating activities | ||||||||||
Net income | -61.61M | -62.49M | -77.70M | -78.20M | -84.30M | -88.32M | -64.02M | -66.37M | -45.49M | -30.93M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 3.25M | 3M | 2.51M | 2.99M | 2.60M | 2.56M | 2.19M | 2.35M | 1.79M | 888K |
Stock-based compensation expense | 5.38M | 10.62M | 22.04M | 16.46M | 12.61M | 0 | 13.93M | 8.77M | 8.38M | 9.62M |
| Deferred income tax benefit | 5.38M | 10.62M | 22.04M | 16.46M | 12.61M | 0 | 13.93M | 8.77M | 8.38M | 9.62M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -234K | -96K | -770K | 1.59M | -1.36M | 86K | -1.91M | 43K | 1K | -54K |
Inventories | 446K | -236K | -415K | -1.35M | -3.65M | -4.22M | -7.75M | 0 | 0 | 0 |
Accounts payable | 295K | 2.92M | 273K | -1.00M | 988K | 0 | 1.06M | 0 | 329K | 0 |
Cash generated by operating activities | -40.19M | -48.72M | -47.32M | -50.39M | -64.79M | -67.75M | -55.74M | -53.40M | -35.12M | -18.78M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -27.50M | -30.08M | -46.93M | -50.22M | 0 | -82.33M | 0 | -12.41M | 0 |
Investments In Property Plant And Equipment | -1.03M | -554K | -603K | -1.36M | -330K | -998K | -2.96M | -2.40M | -3.65M | -1.93M |
Acquisitions Net | 0 | -12.97M | -8.90M | -14.96M | -53.14M | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 8.66M | 12.41M | 8.30M | 13.60M | 52.81M | -20.13M | -25.72M | -49.56M | -2.67M | -3.37M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 32.91M | 43.58M | 6.42M | 6.82M | 0 | 90.42M | 0 | 104.97M | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | -20.29M | 0 | 0 | -45.06M | 0 | 0 | 0 | 0 |
Repayments of term debt | 8.75M | -1.28M | -360K | -5.21M | 0 | 0 | 0 | -13K | -147K | -107K |
Cash used in financing activities | 9.01M | 31.63M | 43.22M | 11.63M | 6.82M | 125.77M | 90.42M | 1.76M | 104.82M | 45.69M |
Net Change In Cash | -22.76M | -4.99M | 4.11M | -25.23M | -5.24M | 37.74M | 9.26M | -101.34M | 67.02M | 23.53M |
Cash at end of period | 12.13M | 34.90M | 39.89M | 35.78M | 61.01M | 66.26M | 28.51M | 19.24M | 120.58M | 53.56M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |